Autoimmune Clinical Trial Pre-screening: Multi-turn

Data Characteristics for this Category

Autoimmune disease clinical trial pre-screening data originates from global clinical trial registries (e.g., ClinicalTrials.gov, EU Clinical Trials Register), medical literature databases (e.g., PubMed, Embase), patient-reported outcome (PRO) data, and electronic health record (EHR) systems. Data update frequencies vary. Registry information typically updates at key trial milestones, while medical literature increases periodically with publications. Document structures are complex, containing both structured data (e.g., inclusion/exclusion criteria, ICD-10/11 disease codes, ATC drug codes, trial phases, recruitment status, primary/secondary endpoints) and extensive unstructured text (e.g., trial protocol descriptions, adverse event reports, patient medical history). Field specificity is high, including results for autoantibody profiles (ANA, anti-dsDNA, anti-SSA/SSB), disease activity scores (e.g., SLEDAI for lupus, DAS28 for rheumatoid arthritis), and history of specific immunosuppressant use. Units are typically international standard units or commonly used clinical units.

Constraints Imposed by these Characteristics on Multi-turn Conversations and Prompts

The highly mixed structured and unstructured nature of autoimmune disease data requires multi-turn dialogue systems to effectively integrate structured queries with natural language understanding. For example, a user might first provide structured inclusion/exclusion criteria, then refine specific disease activity requirements through natural language. Varying data update frequencies mean the dialogue system needs real-time or near real-time data synchronization capabilities to ensure clinical trial information is current. The extensive medical terminology and abbreviations in documents demand high semantic understanding and entity recognition capabilities from prompts. The system must accurately identify key information like "ANA titer 1:320" or "history of MTX treatment." Additionally, unstructured narratives in patient medical history and adverse event reports require multi-turn clarification of ambiguous information to ensure pre-screening accuracy and prevent disqualification due to missing or misunderstood information.

Configuration Guidelines

Configuration Item	Suggested Value	Rationale for this Value
`maxContext`	`10` turns	Autoimmune disease pre-screening logic is complex; sufficient dialogue history is needed to understand evolving user intent.
`temperature`	`0.3`	Reduces model divergence, ensuring the rigor of screening logic and stability of results.
`Recall count` (Recall Count)	`15` items	Increases the initial recall range to cover more potentially relevant clinical trial records.
`Similarity threshold` (Similarity Threshold)	`0.78`	Balances recall and precision, ensuring screening results are highly relevant to user descriptions.
`Rerank result count` (Reranked Return Count)	`5` items	Prioritizes the most relevant core trial information, reducing user reading burden.
`PARSE_FILE_TIMEOUT_SECONDS`	`300` seconds	Autoimmune trial protocol documents are complex; this allows ample time to parse large PDFs.

Three Common Pitfalls

Phenomenon: Specific antibody test results mentioned by the user in a multi-turn conversation are not correctly recognized as screening criteria. Reason: Prompts do not explicitly guide the model to focus on key values and units in medical laboratory reports, or the entity recognition model is not optimized for specific indicators in the autoimmune field.
Phenomenon: Within the same conversation window, knowledge base retrieval response times significantly increase, or even time out, after multiple queries. Reason: Session variables are not effectively managed, causing each query to carry excessive historical context, increasing the burden on retrieval and model processing.
Phenomenon: When a user attempts to modify a previously confirmed inclusion/exclusion criterion, the system does not update the screening logic according to the new instruction, still using the old criterion. Reason: The multi-turn dialogue's variable update mechanism is not correctly configured, leading to historical variables not being overwritten or priority settings being incorrect.

How to Verify Configuration

Select typical pre-screening scenarios covering various autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus) and conduct multi-turn dialogue tests. Verify if the system accurately identifies and applies all inclusion/exclusion criteria.
Simulate a user progressively refining screening conditions in a conversation and modifying confirmed conditions midway. Verify if the system can correctly update its internal state and perform accurate knowledge base retrieval and result recommendations based on the latest conditions.
Check log outputs to confirm maxContext is correctly applied after each conversation and if knowledge base recall and reranking results fall within the expected threshold range, paying particular attention to the impact of Similarity threshold (Similarity Threshold) on result items.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.